Publication | Closed Access

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

HepatologyViral HepatitisImmunologyHepatitis BHepatitisAntiviral TherapyInterferon NonrespondersChronic Viral InfectionAntiviral DrugLamivudine/interferon Combination TherapyMedicineCirrhosis